TCL Archive In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics September 28, 1979
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography February 14, 1997
TCL Archive Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find October 25, 2002
